Ann: Patrys' PAT-SM6 Inhibits Metastases in M, page-4

re: Ann: Patrys' PAT-SM6 Inhibits Metasta... Hi Marke, couldn't agree more. Someone is still offloading though. Maybe for tax reasons, don't know. Pity I'm full up to the brim (and showing a loss right now on one parcel), but no way would I take the risk of selling and hoping to get back cheaper.

Not saying no-one else should try it. After all, there could be stuff we don't know that someone else does. But I can't think what it would be. Even a cap raising would only lead to further clinical trials and should result in a quantum leap in the share price.

The next half year or so should be great for this little company IMO. (Hope that's not considered unrealistic ramping. If you look at where they sit with their pipeline and achievements to date, I think most people would draw the same conclusion.)